Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence, Risk Factors and Prognosis of Pulmonary Fibrosis During Severe COVID-19 Pneumonia

NCT04987528 is registered in ClinicalTrials.gov with Hôpital Européen Marseille as lead sponsor.

NCT NCT04987528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04987528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence, Risk Factors and Prognosis of Pulmonary Fibrosis During Severe COVID-19 Pneumonia
Lead sponsor
Hôpital Européen Marseille
Phase
Observational
Overall status
Active, not recruiting
Start date
March 11, 2020
Completion date
December 31, 2027
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, pulmonary fibrosis, severe acute respiratory syndrome coronavirus 2